REMOTE-ILD: A clinical trial investigating the impact of using a mobile app for home monitoring on patients’ care

Upcoming study
Expected to open March 2023
This study is currently recruiting
Expected to close July 2024
This study is closed
This study closed in July 2024
We will update this page with study results when available.
Information on study results are included below
This study closed in July 2024

What next?

Original listing:

What next?

Original listing:

About this study

Measuring patients’ lung function is an important part of pulmonary fibrosis care. However, many factors can limit regular access to monitoring, including spirometry (breathing tests). The COVID-19 pandemic has presented additional challenges, highlighting a potential role for complimentary home monitoring options for patients. Home-based spirometry and digital technology mean that patients now have the opportunity to monitor their lung function at home.

The REMOTE-ILD study is investigating the impact of using a mobile app for home monitoring on patient care.

The study aims to understand whether monitoring lung function at home is helpful for patients and clinicians in managing pulmonary fibrosis.

In this study, the impact of regularly performing breathing tests at home in addition to usual (routine) care, is being compared to patients receiving their usual care alone. Participants will be randomly allocated to one of two groups, one monitoring their lung function at home in addition to their routine care, or and one to simply continue with their routine care. 

 – 

What is involved?

Participants who are enrolled on this study will be randomly allocated to either continue with their routine care, or to monitor their breathing at home in addition to their routine care. Participants who will be monitoring their breathing at home will be asked to perform home spirometry and pulse oximetry twice a week for 52 weeks. They will use a mobile app to record their results which will be automatically available for their hospital healthcare team to view. All participants will complete questionnaires. Participants will not need to visit the clinic more often than usual to take part.

Summary of involvement

Assigned to one of two groups:

1. Monitoring breathing at home through home spirometry and pulse oximetry twice per week

2. Continuing with standard care

Completion of questionnaires

Can I take part?

You may be able to take part if you have a diagnosis of pulmonary fibrosis, and have access to a mobile device or tablet, an email address and internet access.

In all studies, there are lots of different reasons why you may or may not be able to take part.  These are known as inclusion and exclusion criteria. Only the study team will be able to fully determine whether you are able to take part.

In research studies, there are lots of different reasons why you may or may not be able to take part. These are known as inclusion and exclusion criteria (see list below). Only the clinical trial team will be able to fully determine whether you are able to take part in the study. You can withdraw at any point.

If you are not able to take part in this research study, there may be other opportunities for you to take part in different studies.

To find our more about other research opportunities visit our research finder main page.

You may be able to join this study if all of these apply:

Diagnosis of fibrotic interstitial lung disease

Aged 18 years and over

Own a smartphone or tablet device

Are able to access the internet at home, have an email address and telephone number

Lung function tests performed within the last 6 months at the hospital or clinical setting

Expecting at least 2 outpatient clinical review appointments within the study period

Willing to monitor breathing at home

Understands how to use mobile technology (downloading apps onto device and using emails)

You will not be able to join the study of any of the following applies:

Unable to fulfil the inclusion criteria

Cognitive impairment

History of difficulties performing spirometry at previous clinical/hospital testing

Contraindications to spirometry (for example previous pneumothorax, unstable cardiac status, known aortic or cerebral aneurysm)

Other serious conditions that put patients at high risk or respiratory distress

Current or recent (within 6 weeks of the first assessment) participation in other research

What difference could taking part make?

Taking part in the REMOTE-ILD study will help researchers to identify the impact of remote monitoring at home. The study will help to gain greater understanding of the impact this has on patients and if it fits within the clinical care.

Taking part in research has the potential to make a difference for people who have PF now and for future generations.

Where does the study take place?

Study locations

London

Exeter

Basingstoke

Winchester

Liverpool

Leeds

This study is currently recruiting participants at multiple sites.

Patients who do not live locally may also be able to take part.

How to take part

If you are interested in taking part or would like more information about this study, you can email:

Imperial.ILDmonitoring@nhs.net

Further information

The summary on this page provides information about an opportunity to participate in research. More detailed information about the study can be found via the following the links and through contacting the research team.

If you have any questions about this research study, please speak to your medical team and contact the researchers directly via:

Imperial.ILDmonitoring@nhs.net

This study is supported by

Study ID number:
NCT05662124

APF does not endorse or recommend any specific study. All responsibility for the study remains with the sponsors and investigators.

Every effort is made to keep these details up to date. If you are aware of any inaccuracies, please email research@actionpf.org